Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Generic Ezetimibe 10 mg vs EZETROL in Healthy Thai Volunteers (Fasting)
TCTR20251222011Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ezetimibe in hypercholesterolemia (2 arms), sponsored by International Bio Service. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20251222011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251222011.